SEARCH

SEARCH BY CITATION

References

  • 1
    Danzinger RG, Hofmann AF, Schoenfield LS, Thistle JL. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972; 286: 18.
  • 2
    Nakagawa S, Makino I, Ishizaki T, Dohi I. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 1977; 2: 367369.
  • 3
    Sauerbruch T, Paumgartner G. Gallstones:pathogenesis. Lancet 1991; 338: 11171124.
  • 4
    Von Bergmann K, Epple-Gutsfeld M, Leiss O. Differences in the effects of chenodeoxycholic acid and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology 1984; 87: 136143.
  • 5
    Nilsell K, Angelin B, Leijd B, Einarsson K. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Gastroenterology 1983; 85: 12481256.
  • 6
    Mazzella G, Parini P, Festi D, Bazzoli F, Aldini R, Roda A, Tonelli D, et al. Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in non-familial hypercholesterolemia. Hepatology 1992; 15: 10721078.
  • 7
    Leiss O, von Bergmann K, Streicher U, Strotkoetter H. Effect of three different dihydroxy bile acids on intestinal cholesterol absorption in normal volunteers. Gastroenterology 1984; 87: 144149.
  • 8
    Roda E, Cipolla A, Salzetta A, Marchetto S, Pezzoli A, Accogli E, Novelli V, et al. Influence of ursodeoxycholic acid on biliary lipids. Scand J Gastroenterol 1994; 29: 1618.
  • 9
    Tint GS, Shefer S. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterology 1986; 91: 10071018.
  • 10
    Angelin B, Nilsell K, Einarsson K. Ursodeoxycholic acid treatment in humans:effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics. Eur J Clin Invest 1986; 16: 169177.
  • 11
    Einarsson K. Effect of ursodeoxycholic acid on hepatic cholesterol metabolism. Scand J Gastroenterol 1994; 29: 1923.
  • 12
    Ponz de Leon M, Carulli N, Loria P, Lori R, Zironi F. Cholesterol absorption during bile acid feeding. Gastroenterology 1984; 78: 214219.
  • 13
    Carulli N, Ponz de Leon M, Zironi F, Pinetti A, Smerieri A, Lori R, Loria P. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short-term feeding of chenodeoxycholic acid and ursodeoxycholic acid. J Lipid Res 1980; 21: 3543.
  • 14
    Maton PN, Ellis HJ, Higgins JP, Dowling RH. Hepatic HMG-CoA reductase activity in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids. Eur J Clin Invest 1980; 10: 325332.
  • 15
    Angelin B, Ewerth S, Einarsson K. Ursodeoxycholic acid treatment in cholesterol gallstone disease:effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels. J Lipid Res 1983; 24: 461468.
  • 16
    Miettinen TA. Detection of changes in human cholesterol metabolism. Ann Clin Res 1970; 2: 300320.
  • 17
    Salen G, Ahrens EH Jr., Grundy SM. Metabolism of betasitosterol in man. J Clin Invest 1970; 49: 652667.
  • 18
    Miettinen TA. Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci 1969; 8: 713721.
  • 19
    Miettinen TA. Precursor sterols related to cholesterol synthesis. In: Sanghvi A, ed. Coordinate regulation of cholesterol metabolism. Proceedings of NATO Meeting, Santa Fe, NM, 1985, pp 87106.
  • 20
    Vuoristo M, Miettinen TA. Serum cholesterol precursor sterols in coeliac disease:effects of glutein free diet and cholestyramine. Gut 1986; 27: 13121319.
  • 21
    Miettinen TA. Effects of bile acid feeding and depletion on plasma and biliary squalene, methyl sterols and lathosterol. In: PaumgartnerG, StiehlA, GerokW, eds. Bile acids and lipids. Lancaster, England: MTP, 1981: 255267.
  • 22
    Tilvis RS, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986; 43: 9297.
  • 23
    Röschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamt Cholesterins in Serum. Z Klin Chem Klin Biochem 1974; 12: 403407.
  • 24
    Wahleweld AW. Triglyceride determination after enzymatic hydrolysis. Methods Enzym Anal 1974; 5: 18311835.
  • 25
    Miettinen TA, Koivisto P. Noncholesterol sterols and bile acid production in hyper-cholesterolemic patients with ileal by-pass. In: PaumgartnerG, StiehlA, GerokW, eds. Bile Acids and Cholesterol in Health and Disease. Lancaster, England: MTP, 1983: 183187.
  • 26
    Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem 1959; 234: 466468.
  • 27
    Thomas PJ, Hofmann AF. A simple calculation of the lithogenic index of the bile. Expressing biliary lip id composition in rectangular coordinates. Gastroenterology 1973; 65: 698700.
  • 28
    Carey MC, Ko G. The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating “percent cholesterol saturation” with a correction factor for ursodeoxycholate-rich bile. In: PaumgartnerG, StiehlA, GerokW, eds. Biological effects of bile acids. Lancaster, England: MTP, 1979: 299308.
  • 29
    DixonWJ, ed. BMDP statistical software. Los Angeles: University of California, 1981.
  • 30
    Björkhem I, Miettinen TA, Reihnér E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987; 28: 11371143.
  • 31
    Miettinen TA, Tilvis R, Kesäniemi YA. Serum plant sterols and cholesterol precursor sterols reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990; 131: 2031.
  • 32
    Kempen HJM, Glatz JFC, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration as an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988; 29: 11491151.
  • 33
    Ahlberg J, Angelin B, Einarsson K. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. J Lipid Res 1981; 22: 410422.
  • 34
    Miettinen TA, Färkkilä M, Vuoristo M, Karvonen A-L, Leino R, Lehtola J, Friman C et al. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Hepatology 1995; 21: 12611268.
  • 35
    Nordby G, Norum K. C. Substrate specificity of lecithin: cholesterol acyltransferase, esterification of desmosterol, b-sitosterol and cholecalciferol in human plasma. Scand J Clin Lab Invest 1975; 35: 677682.
  • 36
    Miettinen TA. Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor. Eur J Clin Pharmacol 1991; 40: S19S21.
  • 37
    Miettinen TA, Kesäniemi YA, Järvinen H, Hästbacka J. Cholesterol precursor sterols, plant sterols, and cholestanol in human bile and gallstones. Gastroenterology 1986; 90: 858864.
  • 38
    Miettinen TE, Kesäniemi YA, Gylling H, Järvinen H, Silvennoinen E, Miettinen TA. Noncholesterol sterols in bile and stones of patients with cholesterol and pigment stones. Hepatology 1996; 23: 274280.